JSW Energy Limited has informed the Exchange about Affirmation of Credit Rating of JSW Renewable Energy (Vijayanagar) Limited
Bharti Airtel Limited has informed the Exchange about press release dated 18-Nov-2022 titled Airtel powers Lal Bahadur Shastri International Airport, Varanasi with ultrafast Airtel 5G Plus.
Aurobindo Pharma Limited is pleased to announce that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received a final approval from the US Food & Drug Administration (USFDA) for Amphotericin B Liposome for Injection, 50 mg. Amphotericin B Liposome for Injection, 50 mg/vial Single-Dose Vial to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), AmBisome Liposome for Injection, 50 mg/vial, of Astellas Pharma US, Inc.. The product is expected to be launched by Q4 FY23. The approved product has an estimated market size of around US$ 145 million for the twelve months ending September 2022, according to IQVIA.
COMPLIANCE OF REGULATION 30 OF SEBI (LODR), 2015- DISCLOSURE OF EVENTS OR INFORMATION ??? CESSATION OF DIRECTORS
LG Balakrishnan & Bros Limited has informed the Exchange about Notice of Postal Ballot
Indian Energy Exchange Limited has informed the Exchange about Closure of trading window
GI Engineering Solutions Limited has informed the Exchange about appointment of Mr. Deepak as Compliance Officer of the company w.e.f. 05-Nov-2022
Agarwal Industrial Corporation Limited has informed the Exchange about press release dated 18-Nov-2022 titled Press Release of Un-audited Financial Results for the Quarter and Half Year ended on 30th September, 2022 for Investor Meet
Maruti Suzuki India Limited has informed the Exchange about press release dated 18-Nov-2022 titled India???s favourite hatchback, All-New Alto K10 now available with S-CNG technology

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.